Message from the Founder
at September 8, 2015 8:08 am
September 17, 2015, 3:37 am
Comments are closed.
Rhema Health Products receives Health Canada approval with NPN Registration Number for Curcumin BDM30™ – Breakthrough discovery at Biologic Pharmamedical Research.
New Curcumin Ingredient Aims for High Level of One Specific Curcuminoid to Boost Anti-Inflammatory Activity
Review of Amyotrophic Lateral Sclerosis, Parkinson’s and Alzheimer’s diseases helps further define pathology of the novel paradigm for Alzheimer’s with heavy metals as primary disease cause.
New biomedical research released today jointly by The Rhema Group and Biologic Pharmamedical
Registered* Pharmaceutical Drugs Today
of these Registered* Drugs are Nutraceuticals
% of all Prescription Drugs at 1980 Contained Extracts from Plant Sources
% of this 25%** are now Produced Synthetically